Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
about
Clinical observation of docetaxel or gemcitabine combined with cisplatin in the chemotherapy after surgery for stage II-III non-small cell lung cancerConcurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.Effects of icotinib on early-stage non-small-cell lung cancer as neoadjuvant treatment with different epidermal growth factor receptor phenotypes.Stellettin B Induces G1 Arrest, Apoptosis and Autophagy in Human Non-small Cell Lung Cancer A549 Cells via Blocking PI3K/Akt/mTOR PathwayAdjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?Preoperative pulmonary rehabilitation for marginal-function lung cancer patients.Effects of p38MAPK-mediated excision repair cross-complementation 1 expression on prognosis of patients with non-small cell lung cancer.Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France.Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System.Clinical observation of docetaxel or gemcitabine combined with cisplatin in the chemotherapy after surgery for stage II-III non-small cell lung cancer.Q58736026
P2860
Q33427467-FA487E58-E945-46A9-883A-FB1B60DCA0CDQ33432452-D34DEC34-5B3E-4097-841D-36088EA1A409Q35532904-2F8AA1F5-FDAE-4AB3-96A8-03762AB6CA61Q36733598-8181BC9F-3A37-4933-81D9-4BFC08DFAB7CQ36950643-6B345B2F-D19A-4036-9B88-FD04C374BA33Q38831491-9314A24F-AB8F-4279-8F0A-C6D6A0247876Q40443946-9CC79E33-A75A-4B3B-A177-9CEE83A521A6Q41615810-657BB2CC-0F1D-4F8E-8D70-2FDF1D930AB0Q43604978-5E0AE5AB-CF2B-4508-A024-A5430C62227FQ49441931-4962F196-804D-4333-B674-B5E0E6373057Q51566880-AD9AFD48-B8FC-47CF-87E7-5C209B29DA00Q58736026-00FB679A-7391-4955-AC2D-3A7A7EB909E8
P2860
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@ast
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@en
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@nl
type
label
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@ast
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@en
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@nl
prefLabel
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@ast
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@en
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@nl
P2860
P356
P1433
P1476
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
@en
P2093
T Le Chevalier
P2860
P304
P356
10.1093/ANNONC/MDQ376
P478
21 Suppl 7
P577
2010-10-01T00:00:00Z